Redundancy of Direct Priming and Cross-Priming in Tumor-Specific CD8+ T Cell Responses
- 1 October 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (7) , 3577-3584
Abstract
Against a subset of human cancers, vigorous tumor-specific CD8+ T cell responses can develop either spontaneously or upon allogeneic transplantation. However, the parameters that determine the induction of such pronounced anti-tumor immunity remain ill defined. To dissect the conditions required for the induction of high magnitude T cell responses, we have developed a murine model system in which tumor-specific T cell responses can be monitored directly ex vivo by MHC tetramer technology. In this model, tumor challenge of naive mice with Ag-bearing tumor cells results in a massive Ag-specific T cell response, followed by CD8+ T cell-dependent tumor rejection. We have subsequently used this model to assess the contribution of direct priming and cross-priming in the induction of tumor immunity in a well-defined system. Our results indicate that direct priming of T cells and Ag cross-priming are redundant mechanisms for the induction of tumor-specific T cell immunity. Moreover, T cell responses that arise as a consequence of Ag cross-presentation can occur in the absence of CD4+ T cell help and are remarkably robust.Keywords
This publication has 42 references indexed in Scilit:
- Cross-Presentation, Dendritic Cells, Tolerance and ImmunityAnnual Review of Immunology, 2001
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Duration of TCR Stimulation Determines Costimulatory Requirement of T CellsImmunity, 1996
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- T cell deletion follows chronic antigen specific T cell activation in vivoInternational Immunology, 1993
- Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymusCell, 1993
- Empty MHC class I molecules come out in the coldNature, 1990
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Helper activity is required for the in vivo generation of cytotoxic T lymphocytesJournal of Experimental Medicine, 1982
- Comparative studies on the induction of transplantation resistance in BALB/c and C57BL/6 mice in three murine leukemia systemsTransplantation, 1968